(Q35753371)

10 August 2017

1 reference

title

Combating opiate dependence: a comparison among the available pharmacological options (English)

1 reference

10 August 2017

1 reference

Gerardo Gonzalez

1

1 reference

10 August 2017

Alison Oliveto

series ordinal

2

1 reference

10 August 2017

Thomas R Kosten

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

Expert Opinion on Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

5

1 reference

10 August 2017

issue

4

1 reference

10 August 2017

page(s)

713-725

1 reference

Treatment for opioid dependence: quality and access

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

An epidemiologic evaluation of long-term methadone maintenance treatment for heroin addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Mortality Rates of Persons Entering Methadone Maintenance: A Seven-Year Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Retention in methadone maintenance and heroin addicts' risk of death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Mortality in heroin addiction: impact of methadone treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

The cost-effectiveness of methadone maintenance as a health care intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Clinical experiences with 959 opioid-dependent patients treated with levo-alpha-acetylmethadol (LAAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Outcome-oriented standards and performance indicators for substance dependency rehabilitation programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Including narcotic addiction treatment in an office-based practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Methadone maintenance patients in general medical practice. A preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Injecting misuse of buprenorphine among French drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Relationship of plasma buprenorphine and norbuprenorphine to withdrawal symptoms during dose induction, maintenance and withdrawal from sublingual buprenorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Examining the limits of the buprenorphine interdosing interval: daily, every-third-day and every-fifth-day dosing regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Naltrexone shortened opioid detoxification with buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Opiate detoxification of methadone maintenance patients using lefetamine, clonidine and buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Comparison of methadone and high dosage buprenorphine users in French care centres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Recent evolution in opiate dependence in France during generalisation of maintenance treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Deaths involving buprenorphine: a compendium of French cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

A new series of 13 buprenorphine-related deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Effects of buprenorphine/naloxone in opioid-dependent humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Accelerated lofexidine treatment regimen compared with conventional lofexidine and methadone treatment for in-patient opiate detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Double-blind study of lofexidine and clonidine in the detoxification of opiate addicts in hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Catecholaminergic mechanisms of reinforcement: direct assessment by drug-self-administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Two cases of clonidine abuse/dependence in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Double-blind randomised controlled trial of lofexidine versus clonidine in the treatment of heroin withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Lofexidine versus clonidine in rapid opiate detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Clonidine and naltrexone in the outpatient treatment of heroin withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Primary care-based ambulatory opioid detoxification: the results of a clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Clinical Utility of Rapid Clonidine-naltrcxone Detoxification for Opioid Abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Acute blocking of naloxone-precipitated opiate withdrawal symptoms by methohexitone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

A death following ultra-rapid opiate detoxification: the General Medical Council adjudicates on a commercialized detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Rapid opioid detoxification during general anesthesia: a review of 20 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Rapid and ultrarapid opioid detoxification techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Compliance to naltrexone treatment after ultra-rapid opiate detoxification: an open label naturalistic study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Ultra-rapid opiate detoxification using deep sedation with oral midazolam: short and long-term results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Safety, efficacy, and long-term results of a modified version of rapid opiate detoxification under general anaesthesia: a prospective study in methadone, heroin, codeine and morphine addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

The efficacy of naltrexone in preventing reabuse of heroin after detoxification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Follow-up after a six-month maintenance period on naltrexone versus placebo in heroin addicts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Clinical evaluation of a naltrexone sustained-release preparation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Depot naltrexone: long-lasting antagonism of the effects of heroin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Maintenance treatment with depot opioid antagonists in subcutaneous implants: an alternative in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Psychological stress, drug-related cues and cocaine craving.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Stress-induced craving and stress response in cocaine dependent individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Clonidine blocks stress-induced reinstatement of heroin seeking in rats: an effect independent of locus coeruleus noradrenergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Stress reinstates heroin-seeking in drug-free animals: an effect mimicking heroin, not withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Evaluation of buprenorphine maintenance treatment in a French cohort of HIV-infected injecting drug users.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Trends in opiate and opioid poisonings in addicts in north-east Paris and suburbs, 1995-99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

Buprenorphine treatment of opioid dependence: A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.5.4.713

21 January 2018

Identifiers

DOI

10.1517/14656566.5.4.713

1 reference

10 August 2017

1 reference